Literature DB >> 15367059

Possible increased efficacy of low-dose clozapine when combined with aripiprazole.

Sabina Lim, Catalin Pralea, Jerome Schnitt, Malcolm B Bowers, Chandra Cooper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15367059     DOI: 10.4088/jcp.v65n0918d

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  6 in total

Review 1.  Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

Authors:  Constantin Tranulis; Leila Skalli; Pierre Lalonde; Luc Nicole; Emmanuel Stip
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

2.  Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation.

Authors:  Marc Ziegenbein; Georg Wittmann; Stefan Kropp
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

3.  Role of aripiprazole in treatment-resistant schizophrenia.

Authors:  Nilufar Mossaheb; Rainer M Kaufmann
Journal:  Neuropsychiatr Dis Treat       Date:  2012-05-29       Impact factor: 2.570

4.  A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder.

Authors:  Leslie Citrome
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

5.  Current perspectives in the treatment of resistant schizophrenia.

Authors:  R K Solanki; Paramjeet Singh; Deepti Munshi
Journal:  Indian J Psychiatry       Date:  2009 Oct-Dec       Impact factor: 1.759

6.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.